Yumanity Therapeutics (FRA:8IY) Debt-to-Revenue : 0.04 (As of Sep. 2022)

Yumanity Therapeutics Debt-to-Revenue Chart

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Debt-to-Revenue	Get a 7-Day Free Trial							4.61	9.09	2.66	0.17	0.04

Competitive Comparison of Yumanity Therapeutics's Debt-to-Revenue

For the Biotechnology subindustry, Yumanity Therapeutics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yumanity Therapeutics's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Yumanity Therapeutics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Yumanity Therapeutics's Debt-to-Revenue falls into.

Yumanity Therapeutics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Yumanity Therapeutics's Debt-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Yumanity Therapeutics's annualized Debt-to-Revenue for the quarter that ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2022) Revenue data.

Yumanity Therapeutics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Yumanity Therapeutics (FRA:8IY) Business Description